22. Haseeb, S., B. Alexander, and A. Baranchuk. “Wine and Cardiovascular Health: A Comprehensive Review.” Circulation 136, no. 15 (2017): 1434–1448.
23. Covas, M. I., et al. “Wine and Oxidative Stress: Up-to-Date Evidence of the Effects of Moderate Wine Consumption on Oxidative Damage in Humans.” Atherosclerosis 208, no. 2 (2010): 297–304.
24. См. примечания 1 и 10 выше.
25. Biagi, M., and A. A. Bertelli. “Wine, Alcohol and Pills: What Future for the French Paradox?” Life Sciences 131 (2015): 19–22.
26. Sato, M., N. Maulik, and D. K. Das. “Cardioprotection with Alcohol: Role of Both Alcohol and Polyphenolic Antioxidants.” Annals of the New York Academy of Sciences 957 (2002): 122–135; Guiraud, A., et al. “Cardioprotective Effect of Chronic Low Dose Ethanol Drinking: Insights into the Concept of Ethanol Preconditioning.” Journal of Molecular and Cellular Cardiology 36, no. 4 (2004): 561–566; Marfella, R., et al. “Effect of Moderate Red Wine Intake on Cardiac Prognosis After Recent Acute Myocardial Infarction of Subjects with Type 2 Diabetes Mellitus.” Diabetic Medicine 23, no. 9 (2006): 974–981.
27. Karatzi, K. N., et al. “Red Wine Acutely Induces Favorable Effects on Wave Reflections and Central Pressures in Coronary Artery Disease Patients.” American Journal of Hypertension 18, no. 9 Pt 1 (2005): 1161–1167; Stranges, S., et al. “Relationship of Alcohol Drinking Pattern to Risk of Hypertension: A Population-Based Study.” Hypertension 44, no. 6 (2004): 813–819.
28. Xin, X., et al. “Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials.” Hypertension 38, no. 5 (2001): 1112–1117.
29. Lazarus, R., D. Sparrow, and S. T. Weiss. “Alcohol Intake and Insulin Levels. The Normative Aging Study.” American Journal of Epidemiology 145, no. 10 (1997): 909–916.
30. Koppes, L. L., et al. “Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A Meta-Analysis of Prospective Observational Studies.” Diabetes Care 28, no. 3 (2005): 719–725.
31. Shai, I., et al. “Glycemic Effects of Moderate Alcohol Intake Among Patients with Type 2 Diabetes: A Multicenter, Randomized, Clinical Intervention Trial.” Diabetes Care 30, no. 12 (2007): 3011–3016.
32. Corrao, G., et al. “Alcohol and Coronary Heart Disease: A Meta-Analysis.” Addiction 95, no. 10 (2000): 1505–1523.
33. Szmitko, P. E., and S. Verma. “Antiatherogenic Potential of Red Wine: Clinician Update.” American Journal of Physiology-Heart and Circulatory Physiology 288, no. 5 (2005): H2023–2030.
34. Shai, I., et al. “Glycemic Effects of Moderate Alcohol Intake Among Patients with Type 2 Diabetes: A Multicenter, Randomized, Clinical Intervention Trial.” Diabetes Care 30, no. 12 (2007): 3011–3016; Brand-Miller, J. C., et al. “Effect of Alcoholic Beverages on Postprandial Glycemia and Insulinemia in Lean, Young, Healthy Adults.” American Journal of Clinical Nutrition 85, no. 6 (2007): 1545–1551.
35. “The History of Coffee.” Сайт NCA. Открыто по адресу www.ncausa.org/about-coffee/history-of-coffee.
36. Ibid.
37. O’Keefe, J. H., et al. “Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality.” Journal of the American College of Cardiology 62, no. 12 (2013): 1043–1051.
38. van Dam, R. M., and F. B. Hu. “Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review.” JAMA 294, no. 1 (2005): 97–104.
39. Ohnaka, K., et al. “Effects of 16-Week Consumption of Caffeinated and Decaffeinated Instant Coffee on Glucose Metabolism in a Randomized Controlled Trial.” Journal of Nutrition and Metabolism 2012 (2012): 207426.
40. Ibid.
41. Keijzers, G. B., et al. “Caffeine Can Decrease Insulin Sensitivity in Humans.” Diabetes Care 25, no. 2 (2002): 364–369.
42. Ding, M., et al. “Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-Analysis.” Diabetes Care 37, no. 2 (2014): 569–586; Huxley, R., et al. “Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus: A Systematic Review with Meta-Analysis.” Archives of Internal Medicine 169, no. 22 (2009): 2053–2063.
43. Iso, H., et al. “The Relationship Between Green Tea and Total Caffeine Intake and Risk for Self-Reported Type 2 Diabetes Among Japanese Adults.” Annals of Internal Medicine 144, no. 8 (2006): 554–562.
44. DiNicolantonio, J. J., S. C. Lucan, and J. H. O’Keefe. “Is Coffee Harmful? If Looking for Longevity, Say Yes to the Coffee, No to the Sugar.” Mayo Clinic Proceedings 89, no. 4 (2014): 576–577.
45. Wedick, N. M., et al. “Effects of Caffeinated and Decaffeinated Coffee on Biological Risk Factors for Type 2 Diabetes: A Randomized Controlled Trial.” Nutrition Journal 10 (2011): 93.
46. O’Keefe, J. H., J. J. DiNicolantonio, and C. J. Lavie. “Coffee for Cardioprotection and Longevity.” Progress in Cardiovascular Disease 61, no. 1 (2018).
47. de Koning Gans, J. M., et al. “Tea and Coffee Consumption and Cardiovascular Morbidity and Mortality.” Arteriosclerosis, Thrombosis, and Vascular Biology 30, no. 8 (2010): 1665–1671.
48. Poole, R., et al. “Coffee Consumption and Health: Umbrella Review of Meta-Analyses of Multiple Health Outcomes.” The BMJ 359 (2017): j5024.
49. Gunter, M. J., et al. “Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study.” Annals of Internal Medicine 167, no. 4 (2017): 236–247.
50. Ding, M., et al. “Association of Coffee Consumption with Total and Cause-Specific Mortality in 3 Large Prospective Cohorts.” Circulation 132, no. 24 (2015): 2305–2315.
51. Renouf, M., et al. “Plasma Appearance and Correlation Between Coffee and Green Tea Metabolites in Human Subjects.” British Journal of Nutrition 104, no. 11 (2010): 1635–1640.
52. Ojha, S., et al. “Neuroprotective Potential of Ferulic Acid in the Rotenone Model of Parkinson’s Disease.” Drug Design, Development and Therapy (2015): 5499–5510; Madeira, M. H., et al. “Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.” Mediators of Inflammation 2017 (2017): 4761081.
53. Ma, Z. C., et al. “Ferulic Acid Induces Heme Oxygenase-1 via Activation of ERK and Nrf2.” Drug Discoveries & Therapeutics 5, no. 6 (2011): 299–305.
54. Graf, E. “Antioxidant Potential of Ferulic Acid.” Free Radical Biology & Medicine 13, no. 4 (1992): 435–448.
55. Ren, Z., et al. “Ferulic Acid Exerts Neuroprotective Effects Against Cerebral Ischemia/ReperfusionInduced Injury via Antioxidant and Anti-Apoptotic Mechanisms In Vitro and In Vivo.” International Journal of Molecular Medicine 40, no. 5 (2017): 1444–1456.
